Michael Castagna
Net worth: 9 M $ as of 2026-05-30
Net worth: 9 M $ as of 2026-05-30
Michael E.
Castagna is Chief Executive Officer & Director at MannKind Corp.
since 2017, President, Chief Executive Officer & Director at scPharmaceuticals, Inc. starting in 2025, and Director at Pet Partners.
Former roles include Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. from 2005 to 2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010, and VP & Head-North America Biopharmaceuticals at Novartis AG.
Education includes a doctorate from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MANNKIND CORPORATION 0.79% | 2026-05-10 | 2,442,310 ( 0.79% ) | 9 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| MANNKIND CORPORATION | Chief Executive Officer | 2017-05-24 |
| SCPHARMACEUTICALS INC. | Chief Executive Officer | 2025-10-06 |
Pet Partners
Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 2016-03-13 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2012-10-31 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | 2010-10-31 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Director/Board Member | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MannKind Corp.
MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Philadelphia College of Pharmacy
Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pet Partners
Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Process Industries |
Select your edition
All financial news and data tailored to specific country editions